Hypermethylated promoters of tumor suppressor genes were identified in Crohn’s disease patients
Tae-Oh Kim, Yu Kyeong Han, Joo Mi Yi
Intest Res. 2020;18(3):297-305.   Published online 2020 Feb 7     DOI: https://doi.org/10.5217/ir.2019.00105
Citations to this article as recorded by Crossref logo
Epigenotoxicity: a danger to the future life
Farzaneh Kefayati, Atoosa Karimi Babaahmadi, Taraneh Mousavi, Mahshid Hodjat, Mohammad Abdollahi
Journal of Environmental Science and Health, Part A.2023; 58(4): 382.     CrossRef
Evaluating the Clinical Performance of a Dual-Target Stool DNA Test for Colorectal Cancer Detection
Zhongxin Wang, Jian Shang, Guannan Zhang, Lingjun Kong, Feng Zhang, Ye Guo, Yaling Dou, Jun Lin
The Journal of Molecular Diagnostics.2022; 24(2): 131.     CrossRef
Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway
Se Lim Kim, Min Woo Shin, Seung Young Seo, Sang Wook Kim
Bioscience Reports.2022;[Epub]     CrossRef
Personalized medicine in inflammatory bowel disease: Perspectives on Asia
Su Hyun Park, Sang Hyoung Park
Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
Landscape of sialylation patterns identify biomarkers for diagnosis and prediction of response to anti-TNF therapy in crohn’s disease
Chenglin Ye, Sizhe Zhu, Yuan Gao, Yabing Huang
Frontiers in Genetics.2022;[Epub]     CrossRef
The role of epigenetic modifications for the pathogenesis of Crohn's disease
M. Hornschuh, E. Wirthgen, M. Wolfien, K. P. Singh, O. Wolkenhauer, J. Däbritz
Clinical Epigenetics.2021;[Epub]     CrossRef
SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt/β-catenin signaling
Dao-Pei Zou, Yang-Mei Chen, Ling-Zhao Zhang, Xiao-Hui Yuan, Yu-Jie Zhang, Adelina Inggawati, Pham Thi Kieu Nguyet, Tian-Wen Gao, Jin Chen
Genes & Diseases.2021; 8(5): 677.     CrossRef